Healthcare Sector Stocks
The Healthcare sector has a total of 1053 stocks, with a combined market cap of $9.01 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 44.89.
Market Cap
9.01T
Revenue
4.59T
Profits
200.76B
PE Ratio
44.89
Profit Margin
4.38%
Dividend Yield
0.39%
1053 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.04T | 1.08% | 2,800,915 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 601.73B | 1.19% | 11,122,983 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 449.45B | 4.21% | 6,568,036 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 384.49B | 1.16% | 13,288,869 | 450.13B |
| 5 | MRK | Merck & Co., Inc. | 315.22B | 3.25% | 13,064,158 | 65.77B |
| 6 | NVS | Novartis AG | 279.12B | 1.28% | 2,368,246 | 56.58B |
| 7 | AZN | AstraZeneca PLC | 264.05B | 0.55% | 3,018,302 | 60.44B |
| 8 | NVO | Novo Nordisk A/S | 227.44B | 1.82% | 9,792,337 | 50.57B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 201.86B | 1.48% | 1,899,526 | 45.20B |
| 10 | AMGN | Amgen Inc. | 200.54B | 3.70% | 2,359,437 | 37.22B |
| 11 | ABT | Abbott Laboratories | 172.14B | 10.71% | 32,761,808 | 45.13B |
| 12 | GILD | Gilead Sciences, Inc. | 169.23B | 3.49% | 7,939,750 | 29.74B |
| 13 | DHR | Danaher Corporation | 145.10B | 2.10% | 4,244,279 | 24.78B |
| 14 | PFE | Pfizer Inc. | 143.28B | 1.29% | 50,049,798 | 63.32B |
| 15 | ISRG | Intuitive Surgical, Inc. | 142.49B | 3.43% | 5,664,543 | 11.03B |
| 16 | CVS | CVS Health Corporation | 135.89B | 0.56% | 12,034,158 | 405.62B |
| 17 | SYK | Stryker Corporation | 126.97B | 4.66% | 2,307,015 | 25.27B |
| 18 | BMY | Bristol-Myers Squibb Company | 123.57B | 3.05% | 10,188,592 | 48.48B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 123.36B | 1.88% | 1,372,671 | 12.22B |
| 20 | MDT | Medtronic plc | 106.96B | 3.84% | 9,709,380 | 36.36B |
| 21 | SNY | Sanofi | 105.65B | 1.21% | 2,892,201 | 54.60B |
| 22 | GSK | GSK plc | 105.02B | 2.57% | 3,978,742 | 43.29B |
| 23 | MCK | McKesson Corporation | 98.50B | 5.65% | 1,329,769 | 403.43B |
| 24 | HCA | HCA Healthcare, Inc. | 85.57B | 1.82% | 1,922,949 | 76.39B |
| 25 | ELV | Elevance Health, Inc. | 80.97B | -4.48% | 2,904,614 | 201.11B |
| 26 | CI | The Cigna Group | 75.08B | -4.70% | 3,402,418 | 277.89B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 69.07B | 2.18% | 730,877 | 14.92B |
| 28 | BSX | Boston Scientific Corporation | 66.32B | 3.67% | 18,789,528 | 20.61B |
| 29 | COR | Cencora, Inc. | 59.92B | 3.85% | 1,602,829 | 328.68B |
| 30 | MDLN | Medline Inc. | 54.01B | 4.23% | 6,298,169 | 29.14B |
| 31 | ARGX | argenx SE | 53.69B | -0.57% | 205,700 | 4.74B |
| 32 | CAH | Cardinal Health, Inc. | 53.57B | 1.68% | 2,607,835 | 250.74B |
| 33 | TAK | Takeda Pharmaceutical Company Limited | 51.98B | 1.70% | 5,977,024 | 28.34B |
| 34 | EW | Edwards Lifesciences Corporation | 50.58B | 0.65% | 5,953,713 | 6.30B |
| 35 | HUM | Humana Inc. | 46.40B | -5.22% | 2,288,962 | 137.20B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 45.44B | 3.42% | 616,318 | 4.45B |
| 37 | BDX | Becton, Dickinson and Company | 44.07B | 3.26% | 1,685,459 | 22.23B |
| 38 | HLN | Haleon plc | 43.95B | 3.69% | 12,670,356 | 14.85B |
| 39 | NTRA | Natera, Inc. | 38.64B | -2.72% | 949,052 | 2.50B |
| 40 | A | Agilent Technologies, Inc. | 38.44B | 1.03% | 1,755,038 | 7.23B |
| 41 | RVMD | Revolution Medicines, Inc. | 38.09B | -2.85% | 1,726,587 | - |
| 42 | ALNY | Alnylam Pharmaceuticals, Inc. | 37.80B | 1.44% | 1,437,397 | 4.29B |
| 43 | TEVA | Teva Pharmaceutical Industries Limited | 37.52B | 2.09% | 4,453,648 | 17.35B |
| 44 | WAT | Waters Corporation | 37.13B | 0.87% | 761,528 | 3.77B |
| 45 | ONC | BeOne Medicines AG | 35.29B | 1.98% | 594,840 | 5.74B |
| 46 | IQV | IQVIA Holdings Inc. | 35.13B | 1.78% | 1,051,140 | 16.63B |
| 47 | ALC | Alcon Inc. | 34.35B | 3.09% | 1,334,734 | 10.63B |
| 48 | RPRX | Royalty Pharma plc | 33.70B | 3.94% | 3,593,718 | 2.44B |
| 49 | ZTS | Zoetis Inc. | 32.24B | 3.19% | 7,408,383 | 9.53B |
| 50 | VEEV | Veeva Systems Inc. | 32.06B | 1.91% | 1,567,443 | 3.32B |
| 51 | CNC | Centene Corporation | 31.55B | -4.08% | 5,242,056 | 178.33B |
| 52 | BIIB | Biogen Inc. | 30.84B | 5.92% | 1,862,252 | 9.94B |
| 53 | DXCM | DexCom, Inc. | 30.09B | 7.22% | 6,640,117 | 4.82B |
| 54 | GEHC | GE HealthCare Technologies Inc. | 29.89B | 3.96% | 6,111,373 | 20.98B |
| 55 | RMD | ResMed Inc. | 29.25B | 2.11% | 1,019,531 | 5.54B |
| 56 | ILMN | Illumina, Inc. | 28.78B | 1.66% | 1,141,902 | 4.39B |
| 57 | MTD | Mettler-Toledo International Inc. | 26.98B | 1.41% | 118,625 | 4.09B |
| 58 | PHG | Koninklijke Philips N.V. | 25.98B | 1.00% | 889,805 | 20.34B |
| 59 | WST | West Pharmaceutical Services, Inc. | 25.61B | 0.96% | 554,944 | 3.22B |
| 60 | MRNA | Moderna, Inc. | 25.06B | -7.51% | 5,593,001 | 2.23B |
| 61 | ROIV | Roivant Sciences Ltd. | 24.40B | -2.75% | 3,990,246 | 8.26M |
| 62 | INCY | Incyte Corporation | 23.30B | 1.36% | 1,367,388 | 5.36B |
| 63 | INSM | Insmed Incorporated | 23.29B | -2.14% | 2,753,872 | 819.56M |
| 64 | DGX | Quest Diagnostics Incorporated | 23.18B | 3.79% | 991,700 | 11.28B |
| 65 | BNTX | BioNTech SE | 23.15B | -0.47% | 669,556 | 3.23B |
| 66 | LH | Labcorp Holdings Inc. | 23.12B | 3.66% | 555,821 | 14.14B |
| 67 | UTHR | United Therapeutics Corporation | 22.46B | -0.52% | 350,858 | 3.17B |
| 68 | STE | STERIS plc | 21.55B | 4.57% | 651,895 | 5.94B |
| 69 | GH | Guardant Health, Inc. | 20.55B | -4.88% | 2,820,025 | 1.08B |
| 70 | VTRS | Viatris Inc. | 20.18B | 3.90% | 9,479,647 | 14.56B |
| 71 | ZBH | Zimmer Biomet Holdings, Inc. | 18.14B | 4.00% | 2,867,369 | 8.41B |
| 72 | GMAB | Genmab A/S | 17.76B | -0.34% | 1,568,350 | 3.90B |
| 73 | NBIX | Neurocrine Biosciences, Inc. | 17.25B | -0.29% | 900,758 | 3.10B |
| 74 | THC | Tenet Healthcare Corporation | 17.16B | 3.57% | 1,194,374 | 21.46B |
| 75 | ASND | Ascendis Pharma A/S | 16.14B | -3.27% | 485,823 | 998.25M |
| 76 | BBIO | BridgeBio Pharma, Inc. | 15.74B | -2.86% | 3,529,132 | 579.96M |
| 77 | MEDP | Medpace Holdings, Inc. | 15.36B | 1.64% | 260,354 | 2.68B |
| 78 | JAZZ | Jazz Pharmaceuticals plc | 15.21B | 1.20% | 430,661 | 4.44B |
| 79 | DVA | DaVita Inc. | 15.02B | 1.04% | 506,810 | 13.84B |
| 80 | COO | The Cooper Companies, Inc. | 14.26B | 3.54% | 1,885,362 | 4.23B |
| 81 | BTSG | BrightSpring Health Services, Inc. | 14.20B | -0.15% | 32,760,782 | 13.65B |
| 82 | SOLV | Solventum Corporation | 14.15B | 4.25% | 1,736,668 | 8.26B |
| 83 | EXEL | Exelixis, Inc. | 14.00B | 0.23% | 2,030,952 | 2.38B |
| 84 | SNN | Smith & Nephew plc | 13.20B | 1.98% | 2,600,458 | 6.16B |
| 85 | ICLR | ICON Public Limited Company | 13.02B | -1.21% | 501,845 | 8.27B |
| 86 | ELAN | Elanco Animal Health Incorporated | 12.96B | 1.61% | 4,097,719 | 4.89B |
| 87 | FMS | Fresenius Medical Care AG | 12.78B | 0.12% | 758,668 | 22.32B |
| 88 | ALGN | Align Technology, Inc. | 12.78B | -1.57% | 1,378,135 | 4.10B |
| 89 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.58B | -0.86% | 238,319 | 1.13B |
| 90 | PEN | Penumbra, Inc. | 12.57B | 0.91% | 657,530 | 1.45B |
| 91 | RVTY | Revvity, Inc. | 12.46B | 0.31% | 1,065,528 | 2.90B |
| 92 | AXSM | Axsome Therapeutics, Inc. | 12.20B | -0.21% | 639,659 | 708.24M |
| 93 | BAX | Baxter International Inc. | 12.06B | 5.42% | 6,942,196 | 11.32B |
| 94 | ABVX | ABIVAX Société Anonyme | 11.76B | 0.61% | 1,556,854 | 5.67M |
| 95 | MOH | Molina Healthcare, Inc. | 11.71B | -3.66% | 1,042,560 | 43.10B |
| 96 | BMRN | BioMarin Pharmaceutical Inc. | 11.60B | 1.78% | 1,302,187 | 3.24B |
| 97 | PODD | Insulet Corporation | 11.39B | 3.23% | 1,498,471 | 2.90B |
| 98 | TECH | Bio-Techne Corporation | 11.18B | 0.41% | 3,424,544 | 1.21B |
| 99 | EHC | Encompass Health Corporation | 11.16B | 2.38% | 892,395 | 6.07B |
| 100 | CRL | Charles River Laboratories International, Inc. | 11.04B | 0.41% | 911,481 | 4.03B |
| 101 | GMED | Globus Medical, Inc. | 10.98B | 2.99% | 2,237,571 | 3.10B |
| 102 | CYTK | Cytokinetics, Incorporated | 10.91B | -2.74% | 1,406,757 | 105.82M |
| 103 | SMMT | Summit Therapeutics Inc. | 10.68B | -8.69% | 3,753,747 | - |
| 104 | RDY | Dr. Reddy's Laboratories Limited | 10.58B | -0.55% | 1,672,326 | 3.58B |
| 105 | KRYS | Krystal Biotech, Inc. | 10.08B | -2.41% | 270,974 | 417.30M |
| 106 | HSIC | Henry Schein, Inc. | 10.05B | 1.26% | 1,743,623 | 13.38B |
| 107 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.05B | -0.62% | 2,578,646 | 622.01M |
| 108 | APGE | Apogee Therapeutics, Inc. | 10.05B | -0.16% | 1,359,073 | - |
| 109 | ENSG | The Ensign Group, Inc. | 10.02B | 3.29% | 600,527 | 5.27B |
| 110 | NUVL | Nuvalent, Inc. | 9.83B | - | - | - |
| 111 | CORT | Corcept Therapeutics Incorporated | 9.63B | 0.17% | 878,072 | 769.10M |
| 112 | TEM | Tempus AI, Inc. | 9.62B | -6.39% | 4,840,741 | 1.36B |
| 113 | KYMR | Kymera Therapeutics, Inc. | 9.38B | -0.11% | 713,656 | 51.48M |
| 114 | UHS | Universal Health Services, Inc. | 9.29B | 3.73% | 955,378 | 17.76B |
| 115 | HALO | Halozyme Therapeutics, Inc. | 9.20B | 2.27% | 1,921,897 | 1.51B |
| 116 | GKOS | Glaukos Corporation | 9.12B | -0.92% | 705,756 | 551.35M |
| 117 | IONS | Ionis Pharmaceuticals, Inc. | 9.03B | -0.15% | 3,805,208 | 1.06B |
| 118 | BRKR | Bruker Corporation | 9.02B | 1.01% | 1,556,734 | 3.46B |
| 119 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.85B | 0.01% | 3,537,556 | 18.07M |
| 120 | OSCR | Oscar Health, Inc. | 8.69B | -5.72% | 6,357,116 | 13.30B |
| 121 | ALKS | Alkermes plc | 8.66B | -0.08% | 1,843,682 | 1.56B |
| 122 | ATR | AptarGroup, Inc. | 8.60B | 4.37% | 579,278 | 3.87B |
| 123 | PRAX | Praxis Precision Medicines, Inc. | 8.59B | -3.21% | 362,604 | 7.46M |
| 124 | QGEN | Qiagen N.V. | 8.58B | 0.65% | 2,495,416 | 2.10B |
| 125 | PTGX | Protagonist Therapeutics, Inc. | 8.49B | -2.54% | 601,998 | 74.06M |
| 126 | RGEN | Repligen Corporation | 8.38B | 0.33% | 828,959 | 763.34M |
| 127 | SYRE | Spyre Therapeutics, Inc. | 8.28B | -7.79% | 1,370,632 | - |
| 128 | HQY | HealthEquity, Inc. | 8.25B | 3.81% | 979,512 | 1.34B |
| 129 | PCVX | Vaxcyte, Inc. | 8.09B | -1.23% | 1,050,203 | - |
| 130 | BIO | Bio-Rad Laboratories, Inc. | 8.05B | 1.78% | 237,474 | 2.59B |
| 131 | IMVT | Immunovant, Inc. | 8.00B | -2.31% | 967,306 | - |
| 132 | IBRX | ImmunityBio, Inc. | 7.80B | -3.62% | 7,706,316 | 140.98M |
| 133 | HIMS | Hims & Hers Health, Inc. | 7.80B | -9.39% | 15,528,481 | 2.37B |
| 134 | TGTX | TG Therapeutics, Inc. | 7.78B | -2.62% | 2,191,681 | 700.35M |
| 135 | AVTR | Avantor, Inc. | 7.69B | 0.54% | 13,194,186 | 6.55B |
| 136 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.27B | -3.28% | 615,652 | 217.17M |
| 137 | PACS | PACS Group, Inc. | 7.22B | 1.40% | 867,071 | 5.43B |
| 138 | MIRM | Mirum Pharmaceuticals, Inc. | 7.16B | -3.01% | 424,635 | 569.61M |
| 139 | LNTH | Lantheus Holdings, Inc. | 6.84B | 0.75% | 528,506 | 1.55B |
| 140 | LQDA | Liquidia Corporation | 6.69B | -3.19% | 1,262,791 | 288.07M |
| 141 | HNGE | Hinge Health, Inc. | 6.65B | 0.27% | 1,350,688 | 646.34M |
| 142 | CHE | Chemed Corporation | 6.63B | 1.80% | 125,029 | 2.54B |
| 143 | PTCT | PTC Therapeutics, Inc. | 6.51B | -0.41% | 1,888,995 | 827.11M |
| 144 | COGT | Cogent Biosciences, Inc. | 6.48B | -3.46% | 2,576,186 | - |
| 145 | XENE | Xenon Pharmaceuticals Inc. | 6.47B | -1.08% | 1,502,079 | 7.50M |
| 146 | GRFS | Grifols, S.A. | 6.29B | 1.66% | 654,805 | 8.58B |
| 147 | SRRK | Scholar Rock Holding Corporation | 6.20B | -4.27% | 1,052,474 | - |
| 148 | CGON | CG Oncology, Inc. | 6.13B | -4.79% | 1,221,660 | 5.07M |
| 149 | BLCO | Bausch + Lomb Corporation | 5.99B | 3.26% | 501,344 | 5.21B |
| 150 | TFX | Teleflex Incorporated | 5.99B | 2.63% | 585,366 | 2.13B |
| 151 | BLTE | Belite Bio, Inc | 5.93B | 0.80% | 116,252 | - |
| 152 | ERAS | Erasca, Inc. | 5.91B | -10.54% | 9,324,913 | - |
| 153 | BLLN | BillionToOne, Inc. | 5.90B | -1.31% | 642,731 | 354.54M |
| 154 | LGND | Ligand Pharmaceuticals Incorporated | 5.87B | 0.06% | 241,727 | 274.48M |
| 155 | DFTX | Definium Therapeutics, Inc. | 5.85B | -3.42% | 3,459,379 | - |
| 156 | AMRX | Amneal Pharmaceuticals, Inc. | 5.76B | 4.88% | 2,321,985 | 3.05B |
| 157 | TWST | Twist Bioscience Corporation | 5.68B | -1.49% | 1,723,525 | 409.48M |
| 158 | TXG | 10x Genomics, Inc. | 5.65B | -2.78% | 4,716,993 | 638.78M |
| 159 | STVN | Stevanato Group S.p.A. | 5.49B | 6.35% | 234,904 | 1.39B |
| 160 | DNTH | Dianthus Therapeutics, Inc. | 5.21B | -4.56% | 1,179,945 | 1.34M |
| 161 | SHC | Sotera Health Company | 5.21B | 0.66% | 2,363,825 | 1.19B |
| 162 | TVTX | Travere Therapeutics, Inc. | 5.14B | -2.57% | 1,438,083 | 536.20M |
| 163 | ORKA | Oruka Therapeutics, Inc. | 5.01B | -4.17% | 560,250 | - |
| 164 | RDNT | RadNet, Inc. | 4.95B | 2.57% | 602,312 | 2.14B |
| 165 | INDV | Indivior Pharmaceuticals, Inc. | 4.95B | -0.83% | 1,746,572 | 1.29B |
| 166 | CRSP | CRISPR Therapeutics AG | 4.78B | -5.45% | 2,101,227 | 4.10M |
| 167 | VCYT | Veracyte, Inc. | 4.73B | -0.49% | 624,314 | 541.74M |
| 168 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.70B | -0.94% | 473,874 | 754.05M |
| 169 | CAI | Caris Life Sciences, Inc. | 4.66B | -5.61% | 3,596,246 | 907.29M |
| 170 | MMSI | Merit Medical Systems, Inc. | 4.51B | 3.44% | 765,381 | 1.54B |
| 171 | LIVN | LivaNova PLC | 4.49B | 3.00% | 630,900 | 1.43B |
| 172 | MMED | MiniMed Group, Inc. | 4.46B | 2.98% | 1,252,524 | 3.10B |
| 173 | WAY | Waystar Holding Corp. | 4.44B | 2.12% | 2,404,185 | 1.16B |
| 174 | MANE | Veradermics, Incorporated | 4.42B | -14.45% | 1,454,715 | - |
| 175 | LEGN | Legend Biotech Corporation | 4.39B | -1.43% | 3,081,271 | 1.14B |
| 176 | NVST | Envista Holdings Corporation | 4.39B | 1.05% | 2,767,980 | 2.81B |
| 177 | ACAD | ACADIA Pharmaceuticals Inc. | 4.39B | -1.12% | 2,189,248 | 1.10B |
| 178 | LFST | LifeStance Health Group, Inc. | 4.38B | 2.92% | 6,770,820 | 1.49B |
| 179 | CELC | Celcuity Inc. | 4.31B | -3.52% | 3,169,029 | - |
| 180 | VKTX | Viking Therapeutics, Inc. | 4.22B | -3.81% | 1,529,125 | - |
| 181 | RLAY | Relay Therapeutics, Inc. | 4.22B | -0.72% | 3,592,403 | 10.68M |
| 182 | ALHC | Alignment Healthcare, Inc. | 4.14B | -4.30% | 3,497,261 | 4.26B |
| 183 | EWTX | Edgewise Therapeutics, Inc. | 4.11B | -6.47% | 691,669 | - |
| 184 | DOCS | Doximity, Inc. | 4.06B | -0.22% | 1,940,480 | 644.86M |
| 185 | ICUI | ICU Medical, Inc. | 4.05B | 2.67% | 297,706 | 2.16B |
| 186 | CON | Concentra Group Holdings Parent, Inc. | 4.05B | 3.53% | 1,032,696 | 2.23B |
| 187 | TNGX | Tango Therapeutics, Inc. | 4.00B | -8.63% | 3,744,629 | 56.99M |
| 188 | IRTC | iRhythm Holdings, Inc. | 3.79B | 1.85% | 471,996 | 787.85M |
| 189 | DYN | Dyne Therapeutics, Inc. | 3.76B | -5.29% | 1,681,833 | - |
| 190 | TLX | Telix Pharmaceuticals Limited | 3.71B | -4.07% | 64,594 | 803.79M |
| 191 | PBLS | Parabilis Medicines, Inc. | 3.70B | -2.84% | 520,576 | - |
| 192 | BKD | Brookdale Senior Living Inc. | 3.65B | 6.70% | 8,059,834 | 3.00B |
| 193 | NAMS | NewAmsterdam Pharma Company N.V. | 3.63B | -2.91% | 1,026,499 | 22.57M |
| 194 | DNLI | Denali Therapeutics Inc. | 3.61B | -1.26% | 2,441,841 | - |
| 195 | HAE | Haemonetics Corporation | 3.57B | 2.37% | 952,048 | 1.33B |
| 196 | ELVN | Enliven Therapeutics, Inc. | 3.55B | -4.33% | 866,958 | - |
| 197 | OGN | Organon & Co. | 3.54B | - | 2,695,586 | 6.16B |
| 198 | ADPT | Adaptive Biotechnologies Corporation | 3.54B | -3.49% | 2,447,739 | 295.41M |
| 199 | NHC | National HealthCare Corporation | 3.51B | 3.92% | 140,635 | 1.53B |
| 200 | ALMS | Alumis Inc. | 3.47B | -5.48% | 1,283,262 | 8.40M |
| 201 | OPCH | Option Care Health, Inc. | 3.47B | 0.05% | 2,382,268 | 5.67B |
| 202 | ARQT | Arcutis Biotherapeutics, Inc. | 3.47B | -0.14% | 1,749,923 | 415.62M |
| 203 | PRVA | Privia Health Group, Inc. | 3.43B | -3.13% | 2,429,482 | 2.25B |
| 204 | IDYA | IDEAYA Biosciences, Inc. | 3.42B | -2.20% | 822,854 | 225.27M |
| 205 | WRBY | Warby Parker Inc. | 3.39B | -1.15% | 2,565,155 | 890.57M |
| 206 | ITGR | Integer Holdings Corporation | 3.38B | 4.25% | 670,800 | 1.86B |
| 207 | RCUS | Arcus Biosciences, Inc. | 3.35B | -4.93% | 1,303,353 | 236.00M |
| 208 | GPCR | Structure Therapeutics Inc. | 3.27B | -7.23% | 654,202 | - |
| 209 | ACHC | Acadia Healthcare Company, Inc. | 3.09B | 4.15% | 4,237,899 | 3.37B |
| 210 | GRAL | GRAIL, Inc. | 3.09B | -3.23% | 430,234 | 156.12M |
| 211 | RARE | Ultragenyx Pharmaceutical Inc. | 2.97B | -4.70% | 1,829,571 | 670.00M |
| 212 | BEAM | Beam Therapeutics Inc. | 2.83B | -7.94% | 4,194,074 | 164.01M |
| 213 | VERA | Vera Therapeutics, Inc. | 2.81B | -7.95% | 1,611,168 | - |
| 214 | IRON | Disc Medicine, Inc. | 2.81B | -3.35% | 513,838 | - |
| 215 | SUPN | Supernus Pharmaceuticals, Inc. | 2.80B | 1.01% | 593,351 | 776.83M |
| 216 | CLDX | Celldex Therapeutics, Inc. | 2.78B | -7.60% | 954,753 | 865.00K |
| 217 | MBX | MBX Biosciences, Inc. | 2.78B | -3.89% | 834,943 | - |
| 218 | XRAY | DENTSPLY SIRONA Inc. | 2.77B | 3.36% | 5,370,664 | 3.68B |
| 219 | ESTA | Establishment Labs Holdings Inc. | 2.72B | 1.85% | 389,134 | 229.58M |
| 220 | QURE | uniQure N.V. | 2.71B | -4.00% | 1,257,234 | 18.09M |
| 221 | ATAI | AtaiBeckley Inc. | 2.63B | 33.40% | 166,025,140 | 3.49M |
| 222 | TMDX | TransMedics Group, Inc. | 2.63B | 0.82% | 749,133 | 635.89M |
| 223 | KOD | Kodiak Sciences Inc. | 2.58B | -2.76% | 463,718 | - |
| 224 | GRDN | Guardian Pharmacy Services, Inc. | 2.56B | 1.00% | 253,433 | 1.46B |
| 225 | MESO | Mesoblast Limited | 2.52B | -2.08% | 950,706 | 65.38M |
| 226 | IMNM | Immunome, Inc. | 2.51B | -3.14% | 1,098,909 | 4.02M |
| 227 | PGNY | Progyny, Inc. | 2.50B | -1.48% | 1,518,439 | 1.29B |
| 228 | TARS | Tarsus Pharmaceuticals, Inc. | 2.48B | 0.33% | 1,520,604 | 535.08M |
| 229 | TRVI | Trevi Therapeutics, Inc. | 2.46B | -4.33% | 3,129,150 | - |
| 230 | VCEL | Vericel Corporation | 2.44B | 2.33% | 406,301 | 292.09M |
| 231 | PBH | Prestige Consumer Healthcare Inc. | 2.40B | 4.63% | 437,895 | 1.09B |
| 232 | NRIX | Nurix Therapeutics, Inc. | 2.39B | -3.27% | 861,458 | 36.77M |
| 233 | MLYS | Mineralys Therapeutics, Inc. | 2.39B | -0.84% | 782,726 | - |
| 234 | KLRA | Kailera Therapeutics, Inc. | 2.37B | -5.08% | 397,822 | - |
| 235 | RGC | Regencell Bioscience Holdings Limited | 2.37B | -6.82% | 301,531 | - |
| 236 | LMAT | LeMaitre Vascular, Inc. | 2.35B | 3.25% | 246,305 | 256.28M |
| 237 | PHVS | Pharvaris N.V. | 2.35B | -4.27% | 289,265 | - |
| 238 | ZLAB | Zai Lab Limited | 2.33B | 1.52% | 654,372 | 453.28M |
| 239 | CLOV | Clover Health Investments, Corp. | 2.32B | -5.98% | 5,273,376 | 2.21B |
| 240 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.31B | -3.24% | 3,561,205 | 885.72M |
| 241 | SLS | SELLAS Life Sciences Group, Inc. | 2.31B | -8.13% | 8,992,425 | - |
| 242 | AGIO | Agios Pharmaceuticals, Inc. | 2.30B | -2.88% | 726,914 | 66.05M |
| 243 | NKTR | Nektar Therapeutics | 2.27B | -1.83% | 746,207 | 55.63M |
| 244 | NEOG | Neogen Corporation | 2.25B | 3.51% | 1,814,095 | 870.56M |
| 245 | HTFL | HeartFlow, Inc. | 2.24B | -4.70% | 899,415 | 191.42M |
| 246 | ASTH | Astrana Health, Inc. | 2.24B | -4.12% | 520,266 | 3.53B |
| 247 | SGRY | Surgery Partners, Inc. | 2.16B | 4.72% | 1,140,297 | 3.34B |
| 248 | AVAH | Aveanna Healthcare Holdings Inc. | 2.16B | 3.13% | 3,181,468 | 2.52B |
| 249 | OMCL | Omnicell, Inc. | 2.14B | 0.38% | 467,073 | 1.23B |
| 250 | BHVN | Biohaven Ltd. | 2.13B | -4.64% | 1,406,358 | - |
| 251 | PVLA | Palvella Therapeutics, Inc. | 2.12B | -2.76% | 271,611 | - |
| 252 | AXGN | Axogen, Inc. | 2.12B | 2.72% | 1,323,805 | 238.11M |
| 253 | MD | Pediatrix Medical Group, Inc. | 2.11B | 1.78% | 975,747 | 1.93B |
| 254 | CDNA | CareDx, Inc. | 2.08B | 35.60% | 4,484,183 | 412.82M |
| 255 | ADUS | Addus HomeCare Corporation | 2.08B | 3.31% | 312,963 | 1.45B |
| 256 | IOVA | Iovance Biotherapeutics, Inc. | 2.08B | -1.69% | 28,210,344 | 285.61M |
| 257 | COAG | Hemab Therapeutics Holdings, Inc. | 2.08B | 2.79% | 394,036 | - |
| 258 | AUPH | Aurinia Pharmaceuticals Inc. | 2.05B | -0.99% | 829,988 | 298.30M |
| 259 | SION | Sionna Therapeutics, Inc. | 2.04B | 2.05% | 1,096,312 | - |
| 260 | ADMA | ADMA Biologics, Inc. | 2.04B | 1.50% | 2,726,898 | 509.86M |
| 261 | HCM | HUTCHMED (China) Limited | 2.03B | 0.17% | 36,714 | 548.51M |
| 262 | AGL | agilon health, inc. | 2.02B | -2.47% | 521,915 | 5.82B |
| 263 | SNDX | Syndax Pharmaceuticals, Inc. | 2.01B | -3.44% | 1,597,170 | 217.17M |
| 264 | OCUL | Ocular Therapeutix, Inc. | 2.01B | -7.98% | 2,719,494 | 52.04M |
| 265 | GHRS | GH Research PLC | 2.00B | 8.21% | 1,483,354 | - |
| 266 | VRDN | Viridian Therapeutics, Inc. | 1.99B | -5.40% | 2,097,539 | 70.92M |
| 267 | UFPT | UFP Technologies, Inc. | 1.99B | 4.40% | 219,553 | 608.85M |
| 268 | NUVB | Nuvation Bio Inc. | 1.96B | -4.41% | 4,010,598 | 143.05M |
| 269 | LKFT | Lakefront Biotherapeutics NV | 1.96B | 0.41% | 200,610 | 1.20B |
| 270 | GLUE | Monte Rosa Therapeutics, Inc. | 1.96B | -1.07% | 1,149,615 | 42.95M |
| 271 | URGN | UroGen Pharma Ltd. | 1.95B | 0.50% | 1,241,239 | 140.49M |
| 272 | NBTX | Nanobiotix S.A. | 1.94B | -6.08% | 144,568 | 38.27M |
| 273 | HRMY | Harmony Biosciences Holdings, Inc. | 1.94B | -3.93% | 1,614,360 | 899.11M |
| 274 | NEO | NeoGenomics, Inc. | 1.93B | 2.34% | 4,269,863 | 745.97M |
| 275 | RAPP | Rapport Therapeutics, Inc. | 1.92B | 0.50% | 350,638 | 20.00M |
| 276 | TSHA | Taysha Gene Therapies, Inc. | 1.91B | -3.55% | 4,158,225 | 7.47M |
| 277 | NVCR | NovoCure Limited | 1.90B | 2.43% | 1,117,924 | 674.41M |
| 278 | PLSE | Pulse Biosciences, Inc. | 1.89B | 4.03% | 184,065 | 751.00K |
| 279 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.89B | -4.27% | 937,525 | -665.00K |
| 280 | SNDA | Sonida Senior Living, Inc. | 1.89B | 3.32% | 485,556 | 367.34M |
| 281 | ABCL | AbCellera Biologics Inc. | 1.88B | -8.61% | 7,547,837 | 79.21M |
| 282 | TYRA | Tyra Biosciences, Inc. | 1.88B | -2.38% | 473,621 | - |
| 283 | KARD | Kardigan, Inc. | 1.88B | -4.41% | 378,162 | - |
| 284 | DMRA | Damora Therapeutics, Inc. | 1.86B | -2.29% | 356,039 | - |
| 285 | AAPG | Ascentage Pharma Group International | 1.85B | 1.09% | 2,027 | 82.08M |
| 286 | BHC | Bausch Health Companies Inc. | 1.84B | 0.82% | 1,491,182 | 10.53B |
| 287 | BFLY | Butterfly Network, Inc. | 1.83B | -3.97% | 10,999,541 | 102.92M |
| 288 | WGS | GeneDx Holdings Corp. | 1.83B | -6.73% | 906,256 | 442.68M |
| 289 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.83B | 0.71% | 5,237,983 | 204.73M |
| 290 | SRPT | Sarepta Therapeutics, Inc. | 1.82B | -2.16% | 3,180,760 | 2.18B |
| 291 | BCAX | Bicara Therapeutics Inc. | 1.81B | -1.85% | 445,078 | - |
| 292 | STOK | Stoke Therapeutics, Inc. | 1.81B | -2.67% | 555,052 | 32.08M |
| 293 | ATRC | AtriCure, Inc. | 1.80B | 3.13% | 720,846 | 552.16M |
| 294 | ZBIO | Zenas BioPharma, Inc. | 1.78B | -3.98% | 884,131 | 10.00M |
| 295 | PGEN | Precigen, Inc. | 1.76B | -3.32% | 3,943,713 | 31.60M |
| 296 | IMCR | Immunocore Holdings plc | 1.75B | -0.61% | 762,533 | 412.81M |
| 297 | GENB | Generate Biomedicines, Inc. | 1.75B | -2.91% | 393,235 | 30.30M |
| 298 | ANIP | ANI Pharmaceuticals, Inc. | 1.74B | 1.36% | 242,869 | 923.71M |
| 299 | ZYME | Zymeworks Inc. | 1.73B | -1.91% | 458,794 | 81.26M |
| 300 | ALMR | Alamar Biosciences, Inc. | 1.73B | -4.52% | 421,095 | 87.16M |
| 301 | HCSG | Healthcare Services Group, Inc. | 1.72B | 2.57% | 768,904 | 1.85B |
| 302 | TDOC | Teladoc Health, Inc. | 1.71B | -2.57% | 3,741,700 | 2.51B |
| 303 | FTRE | Fortrea Holdings Inc. | 1.70B | 0.06% | 1,682,931 | 2.71B |
| 304 | MPLT | MapLight Therapeutics, Inc. | 1.69B | -0.29% | 985,435 | - |
| 305 | CMPS | COMPASS Pathways plc | 1.68B | -6.61% | 11,929,833 | - |
| 306 | HROW | Harrow, Inc. | 1.67B | 4.54% | 934,396 | 268.68M |
| 307 | NTLA | Intellia Therapeutics, Inc. | 1.66B | -9.05% | 6,531,741 | 66.09M |
| 308 | INVA | Innoviva, Inc. | 1.64B | 1.46% | 644,095 | 420.69M |
| 309 | PSNL | Personalis, Inc. | 1.63B | -1.33% | 12,870,286 | 64.52M |
| 310 | TRLV | Trulieve Cannabis Corp. | 1.62B | -2.55% | 889,751 | 1.17B |
| 311 | ENOV | Enovis Corporation | 1.62B | 9.69% | 1,369,822 | 2.28B |
| 312 | INNV | InnovAge Holding Corp. | 1.61B | 2.50% | 407,737 | 949.17M |
| 313 | ANAB | AnaptysBio, Inc. | 1.60B | -2.99% | 866,356 | 232.39M |
| 314 | RXRX | Recursion Pharmaceuticals, Inc. | 1.60B | -8.76% | 40,174,578 | 66.41M |
| 315 | VIR | Vir Biotechnology, Inc. | 1.59B | -2.19% | 1,955,015 | 65.50M |
| 316 | MLTX | MoonLake Immunotherapeutics | 1.57B | -4.76% | 1,422,042 | - |
| 317 | IART | Integra LifeSciences Holdings Corporation | 1.54B | 5.70% | 1,316,629 | 1.64B |
| 318 | PRGO | Perrigo Company plc | 1.54B | 9.95% | 3,039,294 | 4.18B |
| 319 | AVBP | ArriVent BioPharma, Inc. | 1.53B | -0.58% | 473,006 | - |
| 320 | MAZE | Maze Therapeutics, Inc. | 1.50B | -7.57% | 819,668 | 20.00M |
| 321 | XERS | Xeris Biopharma Holdings, Inc. | 1.50B | -0.11% | 1,571,771 | 314.85M |
| 322 | INSP | Inspire Medical Systems, Inc. | 1.49B | 2.06% | 882,236 | 915.25M |
| 323 | BLFS | BioLife Solutions, Inc. | 1.48B | 3.81% | 871,648 | 101.66M |
| 324 | ARDT | Ardent Health, Inc. | 1.46B | 4.08% | 559,353 | 6.43B |
| 325 | AHCO | AdaptHealth Corp. | 1.45B | 2.93% | 1,044,927 | 3.29B |
| 326 | PNTG | The Pennant Group, Inc. | 1.45B | 4.09% | 324,397 | 1.02B |
| 327 | STAA | STAAR Surgical Company | 1.44B | 1.68% | 637,365 | 290.38M |
| 328 | ATEC | Alphatec Holdings, Inc. | 1.43B | 2.54% | 2,111,722 | 787.08M |
| 329 | SEPN | Septerna, Inc. | 1.42B | -7.37% | 416,680 | 72.26M |
| 330 | OMDA | Omada Health, Inc. | 1.41B | -0.25% | 1,319,098 | 283.30M |
| 331 | KMTS | Kestra Medical Technologies, Ltd. | 1.41B | -2.60% | 554,734 | 95.13M |
| 332 | PAHC | Phibro Animal Health Corporation | 1.40B | 2.31% | 320,211 | 1.50B |
| 333 | SVRA | Savara Inc. | 1.40B | -4.99% | 1,218,679 | - |
| 334 | ABSI | Absci Corporation | 1.39B | -15.68% | 7,431,764 | 1.84M |
| 335 | AKTS | Aktis Oncology, Inc. | 1.38B | -3.77% | 314,258 | 8.28M |
| 336 | CNMD | CONMED Corporation | 1.36B | 5.19% | 766,183 | 1.37B |
| 337 | NVAX | Novavax, Inc. | 1.35B | -2.25% | 2,403,349 | 596.34M |
| 338 | AHG | Akso Health Group | 1.34B | 1.96% | 2,246 | 14.84M |
| 339 | AMN | AMN Healthcare Services, Inc. | 1.33B | 5.78% | 924,750 | 3.42B |
| 340 | INBX | Inhibrx Biosciences, Inc. | 1.31B | -2.36% | 289,092 | 1.30M |
| 341 | IMTX | Immatics N.V. | 1.28B | -0.74% | 343,267 | 43.00M |
| 342 | ARDX | Ardelyx, Inc. | 1.27B | -3.30% | 2,445,574 | 427.68M |
| 343 | TRAX | First Tracks Biotherapeutics, Inc. | 1.26B | 0.22% | 692,078 | - |
| 344 | IRMD | IRADIMED CORPORATION | 1.25B | 4.43% | 97,387 | 86.28M |
| 345 | AORT | Artivion, Inc. | 1.25B | 5.84% | 878,836 | 458.69M |
| 346 | MNKD | MannKind Corporation | 1.25B | -1.22% | 3,299,581 | 360.78M |
| 347 | QDEL | QuidelOrtho Corporation | 1.24B | 0.05% | 1,136,857 | 2.66B |
| 348 | AZTA | Azenta, Inc. | 1.23B | 0.26% | 660,553 | 596.48M |
| 349 | JBIO | Jade Biosciences, Inc. | 1.22B | -6.31% | 1,284,953 | - |
| 350 | ALVO | Alvotech | 1.20B | -0.30% | 353,187 | 562.04M |
| 351 | CRVS | Corvus Pharmaceuticals, Inc. | 1.20B | -4.36% | 1,257,062 | - |
| 352 | COLL | Collegium Pharmaceutical, Inc. | 1.18B | -1.23% | 379,954 | 796.33M |
| 353 | AVNS | Avanos Medical, Inc. | 1.17B | -0.04% | 759,192 | 715.90M |
| 354 | SDGR | Schrödinger, Inc. | 1.17B | -4.12% | 1,281,772 | 254.91M |
| 355 | MGTX | MeiraGTx Holdings plc | 1.14B | -1.83% | 563,272 | 79.76M |
| 356 | AVLN | Avalyn Pharma Inc. | 1.14B | -6.28% | 289,727 | - |
| 357 | CERT | Certara, Inc. | 1.13B | 3.12% | 4,635,968 | 419.75M |
| 358 | NUTX | Nutex Health Inc. | 1.13B | -6.59% | 175,137 | 879.95M |
| 359 | USPH | U.S. Physical Therapy, Inc. | 1.13B | 3.94% | 357,797 | 787.69M |
| 360 | TNDM | Tandem Diabetes Care, Inc. | 1.12B | 6.61% | 1,983,100 | 1.03B |
| 361 | ORIC | ORIC Pharmaceuticals, Inc. | 1.11B | -3.68% | 1,261,258 | - |
| 362 | XNCR | Xencor, Inc. | 1.11B | -0.20% | 636,626 | 97.36M |
| 363 | CAPR | Capricor Therapeutics, Inc. | 1.11B | -6.04% | 1,489,658 | 11.13M |
| 364 | FBRX | Forte Biosciences, Inc. | 1.10B | 1.90% | 785,917 | - |
| 365 | EYPT | EyePoint, Inc. | 1.09B | -5.85% | 1,551,190 | 7.61M |
| 366 | PRCT | PROCEPT BioRobotics Corporation | 1.09B | 0.26% | 1,586,867 | 322.02M |
| 367 | WVE | Wave Life Sciences Ltd. | 1.09B | -4.06% | 2,461,289 | 71.80M |
| 368 | LMRI | Lumexa Imaging Holdings, Inc. | 1.08B | 1.63% | 261,921 | 1.03B |
| 369 | DRTS | Alpha Tau Medical Ltd. | 1.07B | -4.65% | 783,884 | - |
| 370 | ANRO | Alto Neuroscience, Inc. | 1.06B | -1.76% | 545,904 | - |
| 371 | GDRX | GoodRx Holdings, Inc. | 1.06B | 1.96% | 1,092,306 | 787.89M |
| 372 | GMRS | GMR Solutions Inc. | 1.05B | -3.50% | 407,976 | 5.83B |
| 373 | SPTX | Seaport Therapeutics, Inc. | 1.04B | -4.55% | 96,875 | - |
| 374 | BVS | Bioventus Inc. | 1.04B | 3.84% | 637,339 | 576.30M |
| 375 | IVA | Inventiva S.A. | 1.03B | 1.12% | 869,637 | 7.94M |
| 376 | CRON | Cronos Group Inc. | 1.03B | 0.36% | 834,601 | 159.54M |
| 377 | ETON | Eton Pharmaceuticals, Inc. | 1.02B | -3.40% | 451,924 | 86.93M |
| 378 | CGEM | Cullinan Therapeutics, Inc. | 1.01B | -7.96% | 842,542 | - |
| 379 | PCRX | Pacira BioSciences, Inc. | 1.01B | 1.07% | 776,567 | 734.86M |
| 380 | LXRX | Lexicon Pharmaceuticals, Inc. | 995.00M | 1.82% | 2,736,807 | 69.64M |
| 381 | BIOA | BioAge Labs, Inc. | 985.07M | -2.38% | 528,251 | 10.32M |
| 382 | OLMA | Olema Pharmaceuticals, Inc. | 966.94M | -6.35% | 1,175,968 | - |
| 383 | KURA | Kura Oncology, Inc. | 966.75M | -3.88% | 939,029 | 71.64M |
| 384 | JANX | Janux Therapeutics, Inc. | 965.99M | -1.19% | 648,055 | 13.73M |
| 385 | ANNX | Annexon, Inc. | 965.03M | -9.38% | 7,711,289 | - |
| 386 | SANA | Sana Biotechnology, Inc. | 950.68M | -10.70% | 3,678,477 | - |
| 387 | DBVT | DBV Technologies S.A. | 949.26M | -5.41% | 379,032 | 4.97M |
| 388 | AVTX | Avalo Therapeutics, Inc. | 939.87M | -3.61% | 1,269,518 | 59.00K |
| 389 | VOR | Vor Biopharma Inc. | 939.58M | -4.09% | 849,826 | - |
| 390 | ABUS | Arbutus Biopharma Corporation | 936.33M | 3.95% | 2,895,814 | 191.45M |
| 391 | PHAR | Pharming Group N.V. | 936.04M | -0.82% | 4,240 | 369.49M |
| 392 | GERN | Geron Corporation | 910.96M | - | 6,800,693 | 196.12M |
| 393 | OPK | OPKO Health, Inc. | 898.56M | -0.83% | 3,723,372 | 581.12M |
| 394 | INMD | InMode Ltd. | 896.41M | 2.06% | 1,034,398 | 374.64M |
| 395 | SLDB | Solid Biosciences Inc. | 890.97M | -5.93% | 1,014,326 | - |
| 396 | GLAS | Glass House Brands Inc. | 879.68M | -6.17% | 630,499 | 177.68M |
| 397 | TBPH | Theravance Biopharma, Inc. | 879.53M | 0.24% | 317,482 | 109.78M |
| 398 | LBRX | LB Pharmaceuticals Inc | 877.22M | -4.88% | 186,595 | - |
| 399 | AMPH | Amphastar Pharmaceuticals, Inc. | 875.69M | 2.37% | 416,837 | 720.53M |
| 400 | TALK | Talkspace, Inc. | 874.42M | 0.19% | 1,573,974 | 238.37M |
| 401 | PHAT | Phathom Pharmaceuticals, Inc. | 871.35M | -0.72% | 437,848 | 204.89M |
| 402 | HSTM | HealthStream, Inc. | 845.49M | 2.44% | 150,746 | 311.78M |
| 403 | ODTX | Odyssey Therapeutics, Inc. | 816.80M | -1.10% | 986,732 | 1.06M |
| 404 | AVR | Anteris Technologies Global Corp. | 812.41M | -4.03% | 2,007,445 | 1.85M |
| 405 | REPL | Replimune Group, Inc. | 799.16M | -1.65% | 3,250,002 | - |
| 406 | CTMX | CytomX Therapeutics, Inc. | 797.88M | -0.41% | 4,781,822 | 35.54M |
| 407 | DSGN | Design Therapeutics, Inc. | 787.58M | -6.73% | 900,802 | - |
| 408 | SIBN | SI-BONE, Inc. | 785.87M | 2.72% | 552,845 | 206.22M |
| 409 | RIGL | Rigel Pharmaceuticals, Inc. | 770.98M | 1.19% | 351,629 | 299.77M |
| 410 | TENX | Tenax Therapeutics, Inc. | 770.46M | -1.69% | 925,003 | - |
| 411 | OCS | Oculis Holding AG | 761.49M | -3.89% | 296,579 | 1.40M |
| 412 | AURA | Aura Biosciences, Inc. | 759.96M | -1.71% | 339,529 | - |
| 413 | ZVRA | Zevra Therapeutics, Inc. | 754.31M | -1.54% | 1,084,258 | 122.29M |
| 414 | BBNX | Beta Bionics, Inc. | 753.09M | 0.24% | 687,750 | 110.24M |
| 415 | ACRS | Aclaris Therapeutics, Inc. | 748.60M | -4.29% | 2,096,251 | 8.37M |
| 416 | SPRY | ARS Pharmaceuticals, Inc. | 740.80M | -1.19% | 1,288,262 | 98.99M |
| 417 | CSTL | Castle Biosciences, Inc. | 734.89M | 0.87% | 375,696 | 339.92M |
| 418 | DRUG | Bright Minds Biosciences Inc. | 729.17M | -2.23% | 329,580 | - |
| 419 | NGNE | Neurogene Inc. | 727.33M | -7.48% | 163,515 | 925.00K |
| 420 | MNPR | Monopar Therapeutics Inc. | 726.95M | -0.16% | 193,675 | - |
| 421 | CBLL | CeriBell, Inc. | 726.22M | -1.34% | 530,924 | 95.07M |
| 422 | SSII | SS Innovations International, Inc. | 722.47M | 2.56% | 23,836 | 48.47M |
| 423 | CLYM | Climb Bio, Inc. | 720.34M | -9.30% | 1,507,689 | - |
| 424 | IMMX | Immix Biopharma, Inc. | 716.17M | -4.46% | 1,502,165 | - |
| 425 | GYRE | Gyre Therapeutics, Inc. | 715.76M | -2.13% | 33,703 | 117.05M |
| 426 | EVO | Evotec SE | 704.00M | -1.99% | 71,230 | 859.03M |
| 427 | SLBT | SL Science Holding Limited | 699.84M | 2.12% | 41,413 | - |
| 428 | CADL | Candel Therapeutics, Inc. | 694.60M | -1.66% | 994,658 | - |
| 429 | SGP | SpyGlass Pharma, Inc. | 694.08M | 0.78% | 159,508 | - |
| 430 | PHR | Phreesia, Inc. | 673.13M | 1.21% | 595,909 | 495.59M |
| 431 | FTH | Faeth Therapeutics, Inc. | 668.70M | -17.57% | 662,904 | - |
| 432 | OMER | Omeros Corporation | 667.30M | -11.09% | 2,197,585 | 9.89M |
| 433 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 665.69M | -1.19% | 347,278 | - |
| 434 | TCMD | Tactile Systems Technology, Inc. | 663.38M | 2.83% | 248,507 | 343.52M |
| 435 | MDXG | MiMedx Group, Inc. | 659.83M | 3.75% | 940,490 | 389.42M |
| 436 | CRMD | CorMedix Inc. | 650.37M | -1.54% | 874,704 | 400.05M |
| 437 | CERS | Cerus Corporation | 643.18M | 0.94% | 1,852,814 | 216.56M |
| 438 | EVH | Evolent Health, Inc. | 637.77M | -3.41% | 1,810,466 | 1.89B |
| 439 | IRWD | Ironwood Pharmaceuticals, Inc. | 637.05M | -3.25% | 2,014,462 | 361.51M |
| 440 | ALLO | Allogene Therapeutics, Inc. | 617.83M | -5.79% | 6,300,098 | 22.00K |
| 441 | ACHV | Achieve Life Sciences, Inc. | 611.85M | -5.85% | 1,764,639 | - |
| 442 | AGMB | AgomAb Therapeutics NV | 606.74M | -2.45% | 66,383 | - |
| 443 | CTKB | Cytek Biosciences, Inc. | 599.22M | -0.22% | 877,471 | 204.17M |
| 444 | BWAY | BrainsWay Ltd. | 595.72M | -0.34% | 87,180 | 56.22M |
| 445 | NVCT | Nuvectis Pharma, Inc. | 586.37M | -5.05% | 341,438 | - |
| 446 | WEAV | Weave Communications, Inc. | 584.81M | - | 1,011,129 | 248.72M |
| 447 | MYGN | Myriad Genetics, Inc. | 584.63M | -1.90% | 965,864 | 829.00M |
| 448 | ANGO | AngioDynamics, Inc. | 584.44M | -2.28% | 1,024,012 | 320.17M |
| 449 | FLGT | Fulgent Genetics, Inc. | 583.63M | -2.19% | 227,076 | 320.35M |
| 450 | PRME | Prime Medicine, Inc. | 581.59M | -7.74% | 3,678,781 | 4.03M |
| 451 | RGNX | REGENXBIO Inc. | 579.03M | -8.72% | 2,007,778 | 87.82M |
| 452 | TECX | Tectonic Therapeutic, Inc. | 578.34M | -5.69% | 162,784 | - |
| 453 | RLMD | Relmada Therapeutics, Inc. | 572.70M | -12.08% | 1,874,346 | - |
| 454 | FDMT | 4D Molecular Therapeutics, Inc. | 566.67M | -7.19% | 893,724 | 88.24M |
| 455 | NPCE | NeuroPace, Inc. | 561.52M | 1.60% | 71,107 | 99.53M |
| 456 | ALT | Altimmune, Inc. | 554.25M | -4.36% | 2,995,414 | 36.00K |
| 457 | STTK | Shattuck Labs, Inc. | 542.13M | 4.43% | 2,103,962 | 1.00M |
| 458 | DNA | Ginkgo Bioworks Holdings, Inc. | 541.54M | -7.89% | 1,243,986 | 151.40M |
| 459 | EIKN | Eikon Therapeutics, Inc. | 538.68M | 1.12% | 364,984 | - |
| 460 | TOI | The Oncology Institute, Inc. | 525.91M | -7.07% | 2,560,325 | 545.76M |
| 461 | CTEV | Claritev Corporation | 524.39M | 4.48% | 120,422 | 978.76M |
| 462 | CTNM | Contineum Therapeutics, Inc. | 523.78M | -4.24% | 237,021 | - |
| 463 | KIDS | OrthoPediatrics Corp. | 523.46M | 3.35% | 168,717 | 243.30M |
| 464 | TLRY | Tilray Brands, Inc. | 518.88M | -0.68% | 3,039,405 | 858.28M |
| 465 | ARVN | Arvinas, Inc. | 518.11M | -3.02% | 634,441 | 89.40M |
| 466 | SLN | Silence Therapeutics plc | 515.79M | 4.50% | 567,829 | 839.00K |
| 467 | ASMB | Assembly Biosciences, Inc. | 512.08M | -3.33% | 309,430 | 71.10M |
| 468 | VSTM | Verastem, Inc. | 507.03M | 0.70% | 1,985,572 | 49.59M |
| 469 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 470 | CBIO | Crescent Biopharma, Inc. | 502.09M | -3.57% | 857,483 | 11.88M |
| 471 | ZURA | Zura Bio Limited | 498.74M | -2.60% | 789,475 | - |
| 472 | NRC | NRC Health | 494.46M | 1.29% | 59,855 | 138.64M |
| 473 | AQST | Aquestive Therapeutics, Inc. | 494.34M | -0.25% | 1,921,624 | 50.27M |
| 474 | SOPH | SOPHiA GENETICS SA | 489.11M | 1.04% | 279,722 | 81.18M |
| 475 | PROK | ProKidney Corp. | 486.32M | 0.63% | 1,136,371 | 889.00K |
| 476 | OFIX | Orthofix Medical Inc. | 480.61M | 5.31% | 201,956 | 825.37M |
| 477 | VALN | Valneva SE | 474.71M | -0.97% | 78,668 | 180.25M |
| 478 | SGMT | Sagimet Biosciences Inc. | 472.40M | -4.26% | 835,383 | - |
| 479 | SI | Shoulder Innovations, Inc. | 467.23M | 3.25% | 91,476 | 53.89M |
| 480 | OCGN | Ocugen, Inc. | 463.77M | -4.20% | 5,003,426 | 4.47M |
| 481 | VMD | Viemed Healthcare, Inc. | 463.49M | 1.77% | 443,102 | 286.57M |
| 482 | PACB | Pacific Biosciences of California, Inc. | 462.80M | -2.61% | 4,291,896 | 160.03M |
| 483 | CYH | Community Health Systems, Inc. | 457.83M | 4.97% | 1,694,889 | 12.29B |
| 484 | OVID | Ovid Therapeutics Inc. | 457.27M | -1.61% | 1,515,101 | 7.12M |
| 485 | RZLT | Rezolute, Inc. | 456.52M | -7.81% | 1,072,381 | - |
| 486 | ANL | Adlai Nortye Ltd. | 454.00M | 6.77% | 335,051 | 5.00M |
| 487 | VREX | Varex Imaging Corporation | 453.50M | -0.28% | 292,665 | 857.50M |
| 488 | SRTA | Strata Critical Medical, Inc. | 452.53M | -3.51% | 973,186 | 228.58M |
| 489 | KYTX | Kyverna Therapeutics, Inc. | 452.32M | -4.37% | 1,732,449 | - |
| 490 | CLPT | ClearPoint Neuro, Inc. | 451.64M | -3.89% | 594,984 | 40.61M |
| 491 | DCTH | Delcath Systems, Inc. | 443.60M | -2.50% | 378,337 | 90.44M |
| 492 | PRTA | Prothena Corporation plc | 443.43M | 0.47% | 659,662 | 57.94M |
| 493 | EDIT | Editas Medicine, Inc. | 441.97M | -5.26% | 1,385,666 | 38.69M |
| 494 | ARTV | Artiva Biotherapeutics, Inc. | 439.24M | -8.87% | 626,064 | 251.00K |
| 495 | HELP | Cybin Inc. | 436.37M | 8.14% | 3,780,989 | - |
| 496 | CABA | Cabaletta Bio, Inc. | 435.36M | -3.61% | 2,675,379 | - |
| 497 | BNTC | Benitec Biopharma Inc. | 434.93M | -2.76% | 35,749 | - |
| 498 | PBYI | Puma Biotechnology, Inc. | 427.56M | -0.12% | 400,222 | 227.18M |
| 499 | EVMN | Evommune, Inc. | 421.78M | -5.94% | 646,027 | 10.00M |
| 500 | NNNN | Anbio Biotechnology | 421.36M | 5.26% | 11,899 | 8.65M |